Development of preditection method to prevent occurrence of adult T-cell leukemia/lymphoma (ATLL)
开发预防成人T细胞白血病/淋巴瘤(ATLL)发生的预测方法
基本信息
- 批准号:13557017
- 负责人:
- 金额:$ 8.77万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This project performed following investigations, aiming to predict occurrence of adult T-cell leukemia/lymphoma (ATLL). 1,Peripheral blood tissue specimens (PBTS) of leukemia including ATLL, HTLV-1 carriers and the other lymphocytosis were prepared. 2,Supersensitive immunohistochemistry, new simplified catalyzed signal amplification (nsCSA) system, was established. 3,By the nsCSA system employing anti-HTLV-1 Tax antibody, it was shown that an extremely small amount of Tax was expressed in ATLL cells in tissue specimens includings PBTS. 4,As neoplastic features of HTLV-1-infected cells, expression of Ki67 antigen and p53 protein was examined by the nsCSA system. (1)In HTLV-1 carriers, segmented nuclei of granulocytes were labeled by anti-Ki67 antigen antibody, suggesting an effect of HTLV-1 infection on hematopoiesis. (2)The nsCSA system of p53 1801 antibody detected expression of p53 related to apoptosis, since Ser46 in p53 regulating its function in apoptosis is labeled by p53 1801 an … More tibody. (3)Phosphorylated Ser392 in p53 was labeled by the nsCSA system of p53Phos in ATLL, HTLV-1 carriers and infectious mononucleosis, suggesting inactivation of p53. (4)Expression of p53Phos and p53 1801 antibody was significantly observed in advam\ncing age of HTLV-1 carriers (Kruskal-Walli test). 5,Multi-immunostaing method by an autoimmunostainer was established by introducing classic glycine treatment and blocking non-specific reaction of primary antibody. 6, By the DNA database on the web, it was possible to determine DNA sequence of oligonucleotide probe detecting mRNA of the target DNA. It was known that hybridization solution and detection system to visualize hybridized oligonucleotide probes were important factors in mRNA in-situ hybridization. By means of a sensor of slide glass surface temperature, it was possible to control temperature of tissue section on the slide glass in in-situ PCR method. The next stage detection system expects introduction of the nsCSA system (291 words) Less
该项目进行了调查,旨在预测成人T细胞白血病/淋巴瘤(ATLL)的发生。 1,制备了包括ATLL,HTLV-1载体和其他淋巴细胞增多的白血病的外周血组织标本(PBT)。 2,建立了超敏感的免疫组织化学,新的简化催化信号扩增(NSCSA)系统。 3,通过使用抗HTLV-1税收抗体的NSCSA系统,证明在包括PBT在内的组织样品中的ATLL细胞中表达了极少数的税收。 4,作为HTLV-1感染细胞的肿瘤特征,NSCSA系统检查了Ki67抗原和p53蛋白的表达。 (1)在HTLV-1载体中,通过抗KI67抗原抗体标记粒细胞的分段核会,这表明HTLV-1感染对造血的影响。 (2)p53 1801的NSCSA系统检测到与凋亡相关的p53的表达,因为p53在p53中的Ser46在p53中的Ser46被p53 1801标记为p53 1801 an…更多的tibody。 (3)p53中磷酸化的Ser392在ATLL,HTLV-1载体和感染性单核细胞增多症中的NSCSA系统标记,表明p53失活。 (4)在HTLV-1载体的Advam \ Ring年龄(Kruskal-Walli检测)中,显着观察到p53phos和p53 1801抗体的表达。 5,通过引入经典甘氨酸处理并阻止原代抗体的非特异性反应来建立通过自身免疫剂的多免疫剂。 6,通过网络上的DNA数据库,可以确定靶DNA的mRNA的寡核苷酸探针的DNA序列。众所周知,可视化杂交寡核苷酸问题的杂交解决方案和检测系统是mRNA现场杂交的重要因素。通过幻灯片玻璃表面温度的传感器,可以在原位PCR方法中控制幻灯片玻璃上组织截面的温度。下一个阶段检测系统期望引入NSCSA系统(291个单词)少
项目成果
期刊论文数量(46)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Marin O, Hasui K (Corresponding author), Remondegui C, Sato E, Aye MM, Takenouchi N, Izumo S, Tajima K.: "Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina."Pathology International. 52(5/6). 348-357 (2002)
Marin O、Hasui K(通讯作者)、Remondegui C、Sato E、Aye MM、Takenouchi N、Izumo S、Tajima K.:“阿根廷西北部胡胡伊省的成人 T 细胞白血病/淋巴瘤。”国际病理学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hasui K: "Double autoimmunostaining with glycine treatment"J Histochem Cytochem. 51. 1169-1176 (2003)
Hasui K:“甘氨酸处理的双重自身免疫染色”J Histochem Cytochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hasui K: "Improvement of supersensitive immunohistochemistry with an autostainer : simplified catalyzed signal amplification (CSA) system"The Histochemical Journal. (in press).
Hasui K:“使用自动染色器改进超灵敏免疫组织化学:简化的催化信号放大 (CSA) 系统”《组织化学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
蓮井和久, 宇都宮與, 出雲周二, 早田隆, 津山新一郎, 村田長芳, 佐藤榮一: "末梢白血球静置沈降凝集塊の病理組織標本としての可能性について"日本臨床細胞学会九州連合会雑誌. 32. 159-164 (2001)
Kazuhisa Hasui、Atsushi Utsunomiya、Shuji Izumo、Takashi Hayata、Shinichiro Tsuyama、Nagayoshi Murata、Eiichi Sato:“关于外周白细胞沉淀聚集体作为病理组织标本的可能性”日本临床细胞学会九州联盟杂志 32。 159-164(2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
蓮井和久: "白血病の末梢血の病理組織標本としての有用性について"皮膚のリンフォーマXXI. 21. 134-137 (2002)
Kazuhisa Hasui:“关于白血病外周血作为病理标本的有用性”皮肤淋巴瘤 XXI。21. 134-137 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
共 20 条
- 1
- 2
- 3
- 4
HASUI Kazuhisa的其他基金
Academic project of oncogenic factors in malignant tumors and the related diseases in northeast China
东北地区恶性肿瘤及相关疾病致癌因素学术项目
- 批准号:1940600719406007
- 财政年份:2007
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
Academic research project on oncogenic factors in malignant tumors in the eastnorthern China
中国东北地区恶性肿瘤致癌因素学术研究项目
- 批准号:1640600616406006
- 财政年份:2004
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
Academic research project on oncogenic factors in malignant lymphomas in the east-northern China
中国东北地区恶性淋巴瘤致癌因素学术研究项目
- 批准号:1357600313576003
- 财政年份:2001
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
Oncogenic factors in Chinese gastric lymphoma
中国人胃淋巴瘤的致癌因素
- 批准号:1169121611691216
- 财政年份:1999
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:Grant-in-Aid for Scientific Research (B).Grant-in-Aid for Scientific Research (B).
A STUDY OF HTLV-1-RELATED DISEASES BY MEANS OF HIGHLY SENSITIVE HISTOCHEMISTRY
利用高灵敏组织化学方法研究 HTLV-1 相关疾病
- 批准号:1067016610670166
- 财政年份:1998
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
In-situ-hybridization analysis of HTLV-1-related diseases, employing highly biotinylated probes synthesized by polymerase chain reaction
采用聚合酶链式反应合成的高度生物素化探针对 HTLV-1 相关疾病进行原位杂交分析
- 批准号:0567017605670176
- 财政年份:1993
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:Grant-in-Aid for General Scientific Research (C)Grant-in-Aid for General Scientific Research (C)
相似国自然基金
B23与人类T淋巴细胞白血病病毒1型(HTLV-1)HBZ相互作用及其发病机制研究
- 批准号:81902076
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
去泛素化酶USP5调控P53通路在伴E2A-PBX1成人ALL的致病机制研究
- 批准号:81900151
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
核基质结合区蛋白SATB1调控CCR7抑制急性T淋巴细胞白血病中枢浸润的作用与机制
- 批准号:81870113
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
Sirt1维持HTLV-1感染T细胞持续性潜伏的作用及分子机制
- 批准号:81373135
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
在HTLV-1感染的T细胞中HMGB1、Tax蛋白与细胞自噬关系的研究
- 批准号:81273241
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
Cancer-based discovery of novel mechanisms of chromatin control
基于癌症的染色质控制新机制的发现
- 批准号:1066068010660680
- 财政年份:2023
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:
ETS1-dependent combinatorial control of oncogenic transcription in Notch-activated T-ALL
Notch激活的T-ALL中致癌转录的ETS1依赖性组合控制
- 批准号:1073394510733945
- 财政年份:2023
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:
Mechanisms by which PIM kinase modulates the effector function of autoreactive CD8 T cells in type 1 diabetes
PIM 激酶调节 1 型糖尿病自身反应性 CD8 T 细胞效应功能的机制
- 批准号:1060543110605431
- 财政年份:2023
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:
VLA-4–targeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy
VLA-4™ 靶向 67Cu-LLP2A 预处理增强基于 T 细胞的过继免疫疗法的疗效
- 批准号:1071303410713034
- 财政年份:2023
- 资助金额:$ 8.77万$ 8.77万
- 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:1065108210651082
- 财政年份:2023
- 资助金额:$ 8.77万$ 8.77万
- 项目类别: